These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16297352

  • 1. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
    Huang M, Wu W, Qian J, Wan DJ, Wei XL, Zhu JH.
    Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PEGylated polycyanoacrylate nanoparticles as salvicine carriers: synthesis, preparation, and in vitro characterization.
    Li YP, Zhou ZH, Pei YY, Zhang XY, Gu ZH, Yuan WF.
    Acta Pharmacol Sin; 2001 Jul; 22(7):645-50. PubMed ID: 11749831
    [Abstract] [Full Text] [Related]

  • 4. Stealth PEG-PHDCA niosomes: effects of chain length of PEG on niosomes in vitro complement consumption and phagocytic uptake.
    Shi B, Fang C, You MX, Hong MH, Pei YY.
    Yao Xue Xue Bao; 2005 Nov; 40(11):976-81. PubMed ID: 16499079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of MePEG molecular weight and particle size on in vitro release of tumor necrosis factor-alpha-loaded nanoparticles.
    Fang C, Shi B, Pei YY.
    Acta Pharmacol Sin; 2005 Feb; 26(2):242-9. PubMed ID: 15663906
    [Abstract] [Full Text] [Related]

  • 9. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M, Zhu S, Jiang Y, Tang G, Pei Y.
    J Control Release; 2009 Jan 19; 133(2):96-102. PubMed ID: 18840485
    [Abstract] [Full Text] [Related]

  • 10. [Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats].
    Fang C, Shi B, Hong MH, Pei YY, Chen HZ.
    Yao Xue Xue Bao; 2006 Apr 19; 41(4):305-12. PubMed ID: 16856473
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
    Shan X, Liu C, Yuan Y, Xu F, Tao X, Sheng Y, Zhou H.
    Colloids Surf B Biointerfaces; 2009 Sep 01; 72(2):303-11. PubMed ID: 19450955
    [Abstract] [Full Text] [Related]

  • 13. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y, Xu J, Lin Y, Yu H, Gong T, Li Y, Zhang Z.
    J Biomed Mater Res A; 2008 Nov 01; 87(2):515-23. PubMed ID: 18186066
    [Abstract] [Full Text] [Related]

  • 14. Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate.
    Ishihara T, Kubota T, Choi T, Higaki M.
    J Pharmacol Exp Ther; 2009 May 01; 329(2):412-7. PubMed ID: 19244548
    [Abstract] [Full Text] [Related]

  • 15. PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases.
    Calvo P, Gouritin B, Brigger I, Lasmezas C, Deslys J, Williams A, Andreux JP, Dormont D, Couvreur P.
    J Neurosci Methods; 2001 Oct 30; 111(2):151-5. PubMed ID: 11595281
    [Abstract] [Full Text] [Related]

  • 16. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
    Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M.
    Electrophoresis; 2007 Jul 30; 28(13):2252-61. PubMed ID: 17557357
    [Abstract] [Full Text] [Related]

  • 17. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting.
    Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe MJ, Couvreur P, Vassal G.
    J Pharmacol Exp Ther; 2002 Dec 30; 303(3):928-36. PubMed ID: 12438511
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A, Yang L, Liu W, Li Z, Xu H, Yang X.
    Int J Pharm; 2007 Feb 22; 331(1):123-32. PubMed ID: 17097246
    [Abstract] [Full Text] [Related]

  • 19. Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-alpha carriers: pharmacokinetics and anti-tumor effects.
    Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao XJ, Zhu JH.
    Biol Pharm Bull; 2001 Jun 22; 24(6):662-5. PubMed ID: 11411555
    [Abstract] [Full Text] [Related]

  • 20. In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages.
    Wang Y, Wu W.
    Drug Deliv; 2006 Jun 22; 13(3):189-92. PubMed ID: 16556570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.